New research — co-led by Washington University School of Medicine — has identified the most important features of cancer cells’ protein fragments, which can help distinguish the tumor from healthy tissue, enabling researchers to design better immunotherapies, including vaccines.
A consortium of 17 U.S. cancer centers, including Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, are working together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.
In a mouse study, researchers at Washington University School of Medicine in St. Louis have found that an antibody that targets the protein TREM2 empowers tumor-destroying immune cells and improves the effectiveness of cancer immunotherapy.
Researchers at Washington University School of Medicine have combined two types of immunotherapy into a single treatment that may be more effective and possibly safer than current immunotherapies for blood cancers.
People with the genetic condition neurofibromatosis type 1 are prone to developing tumors on nervous system tissue. A new study from Washington University School of Medicine has found that the development and growth of such tumors are driven by nearby noncancerous neurons and immune cells.
Scientists at Washington University School of Medicine have developed a new imaging agent that could let doctors identify tumors as well as the surrounding normal cells that act as a shield, protecting the tumor from various treatment strategies.
Members of the School of Medicine lab of Matthew Ciorba, MD, have identified a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.
Racial and ethnic minority children and adolescents with cancer have a higher risk of death than non-Hispanic white children and adolescents, with evidence for larger disparities in survival for more treatable cancers, finds a new study from the Brown School at Washington University in St. Louis.
A new study offers a road map to understanding the molecular underpinnings of endometrial cancer, which could lead to new therapies. The national research team was co-led by investigators at the School of Medicine.
A new study from the School of Medicine suggests that bone marrow — or blood stem cells — from healthy donors can harbor extremely rare mutations that can cause health problems for the cancer patients who receive them. Such stem cell transplants are important for treating blood cancers, including acute myeloid leukemia.